Kent SJ - Search Results

1

Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.

Isitman G, Chung AW, Navis M, Kent SJ, Stratov I. Isitman G, et al. Among authors: kent sj. Virology. 2011 Mar 30;412(1):110-6. doi: 10.1016/j.virol.2010.12.044. Epub 2011 Jan 26. Virology. 2011. PMID: 21269655 Free PMC article.

2

Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.

Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA. Kent SJ, et al. J Virol. 1998 Dec;72(12):10180-8. doi: 10.1128/JVI.72.12.10180-10188.1998. J Virol. 1998. PMID: 9811759 Free PMC article.

3

Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.

Kent SJ, Cameron PU, Reece JC, Thompson PR, Purcell DF. Kent SJ, et al. Virology. 2001 Aug 15;287(1):71-8. doi: 10.1006/viro.2001.1019. Virology. 2001. PMID: 11504543 Free article.

4

Vaccination with attenuated simian immunodeficiency virus by DNA inoculation.

Kent SJ, Dale CJ, Preiss S, Mills J, Campagna D, Purcell DF. Kent SJ, et al. J Virol. 2001 Dec;75(23):11930-4. doi: 10.1128/JVI.75.23.11930-11934.2001. J Virol. 2001. PMID: 11689679 Free PMC article.

5

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques.

Dale CJ, Liu XS, De Rose R, Purcell DF, Anderson J, Xu Y, Leggatt GR, Frazer IH, Kent SJ. Dale CJ, et al. Among authors: kent sj. Virology. 2002 Sep 15;301(1):176-87. doi: 10.1006/viro.2002.1589. Virology. 2002. PMID: 12359458 Free article.

6

Vaccines and vaccine strategies against HIV.

Stratov I, DeRose R, Purcell DF, Kent SJ. Stratov I, et al. Among authors: kent sj. Curr Drug Targets. 2004 Jan;5(1):71-88. doi: 10.2174/1389450043490686. Curr Drug Targets. 2004. PMID: 14738219 Review.

7

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.

Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ. Dale CJ, et al. Among authors: kent sj. J Virol. 2004 Dec;78(24):13819-28. doi: 10.1128/JVI.78.24.13819-13828.2004. J Virol. 2004. PMID: 15564490 Free PMC article.

8

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Smith MZ, Dale CJ, De Rose R, Stratov I, Fernandez CS, Brooks AG, Weinfurter J, Krebs K, Riek C, Watkins DI, O'connor DH, Kent SJ. Smith MZ, et al. Among authors: kent sj. J Virol. 2005 Jan;79(2):684-95. doi: 10.1128/JVI.79.2.684-695.2005. J Virol. 2005. PMID: 15613296 Free PMC article.

9

Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.

Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR. Chang JJ, et al. Among authors: kent sj. J Virol. 2005 Mar;79(5):3038-51. doi: 10.1128/JVI.79.5.3038-3051.2005. J Virol. 2005. PMID: 15709024 Free PMC article.

10

Enhanced cellular immunity in macaques following a novel peptide immunotherapy.

Chea S, Dale CJ, De Rose R, Ramshaw IA, Kent SJ. Chea S, et al. Among authors: kent sj. J Virol. 2005 Mar;79(6):3748-57. doi: 10.1128/JVI.79.6.3748-3757.2005. J Virol. 2005. PMID: 15731268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters